The Nottingham health profile: Subjective health status and medical consultations

Hunt, Sonja M.; McKenna, SP; McEwen, James; Williams, J. P.; Papp, E

doi:10.1016/0271-7123(81)90005-5

Cited by 647 publications

(437 citation statements)

References 20 publications

Supporting

Mentioning

394

Contrasting

Unclassified

Order By: Relevance

“…In earlier versions, NHP also contained seven statements about the extent to which such distress impacts daily activities. Although in essence NHP provides a profile of distress in the six dimensions, it is possible to compute a single score based on weighted or unweighted profile scores (32).…”

Section: Nottingham Health Profilementioning

confidence: 99%

Assessment of quality of life in adult patients with GH deficiency: KIMS contribution to clinical practice and pharmacoeconomic evaluations

Kołtowska-Häggström¹,

Mattsson²,

Shalet³

2009

European Journal of Endocrinology

View full text Add to dashboard Cite

Quality of life (QoL) has emerged as an important construct that has found numerous applications across healthcare-related fields, ranging from research and clinical evaluation of treatment effects to pharmacoeconomic evaluations and global healthcare policy. Impairment of QoL is one of the key clinical characteristics in adult GHD and has been extensively studied in the Pfizer International Metabolic Database (KIMS). We provide summarized evidence on GH treatment effects for both clinical and health economic applications based on the KIMS data. The primary focus is on those aspects of QoL research that cannot be investigated in the traditional clinical trial setting, such as specific patient subgroups, cross-country comparisons and long-term follow-up. First, the impact of age, gender, disease onset, primary aetiology, extent of hypopituitarism, previous radiotherapy and obesity on QoL before and during long-term GH replacement is discussed. Secondly, the studies on QoL in relation to country-specific normative values are reviewed. Finally, health economic data derived from KIMS including both burden of disease and utility assessment are evaluated. We conclude that the wide spectrum of analyses performed on the KIMS data allows for practical application of the results not only to research and clinical practice but also to health policy and global medical decision making.

show abstract

Section: Nottingham Health Profilementioning

confidence: 99%

Assessment of quality of life in adult patients with GH deficiency: KIMS contribution to clinical practice and pharmacoeconomic evaluations

Kołtowska-Häggström¹,

Mattsson²,

Shalet³

2009

European Journal of Endocrinology

View full text Add to dashboard Cite

show abstract

“…Furthermore, a number of questions in a generic measurement tool may be inappropriate or irrelevant to a particular problem, or there may be too few items tapping a specific area (in an attempt to ensure a reasonable length). The most popular generic measurement tools are the SF-36 (60), the Sickness Impact Profile (SIP) (87), the Nottingham Health Profile (NHP) (88), and the European Quality of Life Measure (EQ-5D) (89).…”

Section: Generic Measurement Toolsmentioning

confidence: 99%

Pain assessment strategies in patients with musculoskeletal conditions

2012

View full text Add to dashboard Cite

Valid and reliable assessment of pain is fundamental for both clinical trials and effective pain management. The nature of pain makes objective measurement impossible. Chronic musculoskeletal pain assessment and its impact on physical, emotional and social functions require multidimensional qualitative tools and healthrelated quality of life instruments. The recommendations concerning outcome measurements for pain trials are useful for making routine assessments that should include an evaluation of pain, fatigue, disturbed sleep, physical functioning, emotional functioning, patient global ratings of satisfaction, and quality of life. Despite the growing availability of instruments and theoretical publications related to measuring the various aspects of chronic pain, there is still little agreement and no unified approach has been devised. There is, therefore, still a considerable need for the development of a core set of measurement tools and response criteria, as well as for the development and refinement of the related instruments, standardized assessor training, the cross-cultural adaptation of health status questionnaires, electronic data capture, and the introduction of valid, reliable and responsive standardized quantitative measurement procedures into routine clinical care. This article reviews a selection of the instruments used to assess chronic musculoskeletal pain, including validated newly developed and well-established screening instruments, and discusses their advantages and limitations

show abstract

“…A QoL questionnaire was developed based on existing, validated questionnaires focusing on the earlier reported psychological side effects of screening [6,7,8,9,10]. By adding a number of psychosocial items, a more generic concept of QoL to the questionnaire was achieved.…”

Section: Quality Of Life Questionnaire For Population Screening (Scrementioning

confidence: 99%

“…SCREENQOL was designed to have few items. Besides each other, we compared the instruments with NHP [16,17] and the SIP [18] -two widely used health-related QoL instruments that have both demonstrated acceptable levels of validity over a range of patient groups [9,17], and both have been translated with valid back translation.…”

Section: Internal Reliabilitymentioning

confidence: 99%

Validation of Two Global and Generic Quality of Life Questionnaires for Population Screening: SCREENQOL and SEQOL

Ventegodt

Henneberg

Merrick

et al. 2003

The Scientific World JOURNAL

View full text Add to dashboard Cite

The Nottingham health profile: Subjective health status and medical consultations

Cited by 647 publications

References 20 publications

Assessment of quality of life in adult patients with GH deficiency: KIMS contribution to clinical practice and pharmacoeconomic evaluations

Assessment of quality of life in adult patients with GH deficiency: KIMS contribution to clinical practice and pharmacoeconomic evaluations

Pain assessment strategies in patients with musculoskeletal conditions

Validation of Two Global and Generic Quality of Life Questionnaires for Population Screening: SCREENQOL and SEQOL

Contact Info

Product

Resources

About